Home blood pressure and cardiovascular risk in treated hypertensive patients: The prognostic value of the first and second measurements and the difference between them in the HONEST study

Hypertension Research

Volumn 39, Issue 12, 2016, Pages 857-862

  Saito, Ikuo ^a   Kario, Kazuomi ^b   Kushiro, Toshio ^c   Teramukai, Satoshi ^d   Yaginuma, Mai ^e   Mori, Yoshihiro ^e   Okuda, Yasuyuki ^e   Shimada, Kazuyuki ^f  

^a KEIO UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Life Planning Center Foundation   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e DAIICHI SANKYO CO   (Japan)

^f Shin Oyama City Hospital   (Japan)

Author keywords

cardiovascular risk; guideline; home blood pressure monitoring; prognosis

Indexed keywords

OLMESARTAN; ANTIHYPERTENSIVE AGENT; IMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PROGNOSIS; PROSPECTIVE STUDY; SMOKING; AGED; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYPERTENSION; IMIDAZOLES; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TETRAZOLES;

EID: 85002873768     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2016.99     Document Type: Article

References (26)

1. Kario K, Saito I, Kushiro T, Teramukai S, Ishikawa Y, Mori Y, Kobayashi F, Shimada K. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study. Hypertension 2014; 64: 989-996.
2. Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, Nishiyama A, Aihara A, Sekino M, Kikuya M, Ito S, Satoh H, Hisamichi S. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens 1998; 16: 971-975.
3. Asayama K, Ohkubo T, Sato A, Hara A, Obara T, Yasui D, Metoki H, Inoue R, Kikuya M, Hashimoto J, Hoshi H, Satoh H, Imai Y. Proposal of a risk-stratification system for the Japanese population based on blood pressure levels: the Ohasama study. Hypertens Res 2008; 31: 1315-1322.
4. Niiranen TJ, Hänninen MR, Johansson J, Reunanen A, Jula AM. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study. Hypertension 2010; 55: 1346-1351.
5. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion JM. Cardiovascular prognosis of ?masked hypertension? detected by blood pressure selfmeasurement in elderly treated hypertensive patients. JAMA 2004; 291: 1342-1349.
6. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111: 1777-1783.
7. Asayama K, Wei FF, Liu YP, Hara A, Gu YM, Schutte R, Li Y, Thijs L, Staessen JA. Does blood pressure variability contribute to risk stratification?. Methodological issues and a review of outcome studies based on home blood pressure. Hypertens Res 2015; 38: 97-101.
8. Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ishimitsu T, Ito M, Ito S, Itoh H, Iwao H, Kai H, Kario K, Kashihara N, Kawano Y, Kim-Mitsuyama S, Kimura G, Kohara K, Komuro I, Kumagai H, Matsuura H, Miura K, Morishita R, Naruse M, Node K, Ohya Y, Rakugi H, Saito I, Saitoh S, Shimada K, Shimosawa T, Suzuki H, Tamura K, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Umemura S. Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res 2014; 37: 253-390.
9. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F. Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-1357.
10. Niiranen TJ, Johansson JK, Reunanen A, Jula AM. Optimal schedule for home blood pressure measurement based on prognostic data: the Finn-Home Study. Hypertension 2011; 57: 1081-1086.
11. Stergiou GS, Nasothimiou EG, Kalogeropoulos PG, Pantazis N, Baibas NM. The optimal home blood pressure monitoring schedule based on the Didima outcome study. J Hum Hypertens 2010; 24: 158-164.
12. Saito I, Kario K, Kushiro T, Teramukai S, Zenimura N, Hiramatsu K, Kobayashi F, Shimada K. Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study. Hypertens Res 2013; 36: 177-182.
13. Kawabe H, Kanda T, Hirose H, Saito I. Variability of home blood pressure measurements between first and second measurements on one occasion, and factors related to variability. Clin Exp Hypertens 2012; 34: 237-242.
14. Shimada K, Kario K, Kushiro T, Teramukai S, Ishikawa Y, Kobayashi F, Saito I. Differences between clinic blood pressure and morning home blood pressure, as shown by Bland-Altman plots, in a large observational study (HONEST study). Hypertens Res 2015; 38: 876-882.
15. Kario K, Ishikawa J, Pickering TG, Hoshide S, Eguchi K, Morinari M, Hoshide Y, Kuroda T, Shimada K. Morning hypertension: the strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens Res 2006; 29: 581-587.
16. Association for the Advancement of Medical Instrumentation. American National Standard. Electronic or Automated Sphygmomanometers, ANSI/AAMI SP 10-1992. AAMI: Arlington, VA, 1993, p 40.
17. European Committee for Standardization. Non-invasive Sphygmomanometers. Part 3. Supplementary Requirements for Electromechanical Blood Pressure Measuring Systems, British Standard BS EN 1060-3: 1997. European Standard EN 1060-3 1997. ECS: Brussels, Belgium, 1997.
18. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H. Japanese Society of Hypertension Committee. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107.
19. Li Y, Thijs L, Hansen TW, Kikuya M, Boggia J, Richart T, Metoki H, Ohkubo T, Torp-Pedersen C, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Sandoya E, Kawecka-Jaszcz K, Ibsen H, Imai Y, Wang J, Staessen JA. International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes Investigators. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension 2010; 55: 1040-1048.
20. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001; 38: 852-857.
21. Johansson JK, Niiranen TJ, Puukka PJ, Jula AM. Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home Study. Hypertension 2012; 59: 212-218.
22. Stergiou GS, Ntineri A, Kollias A, Ohkubo T, Imai Y, Parati G. Blood pressure variability assessed by home measurements: a systematic review. Hypertens Res 2014; 37: 565-572.
23. Rothwell PM, Howard SC, Dolan E, O?Brien E, Dobson JE, Dahlöf B, Sever PS, Poulter NR. Prognostic significance of visit-To-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375: 895-905.
24. Eto M, Toba K, Akishita M, Kozaki K, Watanabe T, Kim S, Hashimoto M, Ako J, Iijima K, Sudoh N, Yoshizumi M, Ouchi Y. Impact of blood pressure variability on cardiovascular events in elderly patients with hypertension. Hypertens Res 2005; 28: 1-7.
25. Shibasaki S, Hoshide S, Eguchi K, Ishikawa J, Kario K. The Japan Morning Surge-Home Blood Pressure (J-HOP) Study Group. Increase trend in home blood pressure on a single occasion is associated with B-Type natriuretic peptide and the estimated glomerular filtration rate. Am J Hypertens 2015; 28: 1098-1105.
26. Velasco A, Ayers C, Das SR, de Lemos JA, Khera A, Victor RG, Kaplan NM, Vongpatanasin W. Target organ complications and prognostic significance of alerting reaction: analysis from the Dallas heart study. J Hypertens 2016; 34: 226-234.